Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used to identify HER2-positive metastatic breast cancer patients that could be ...

The Council voted to remove the Roche Harbor amendment from the Comprehensive Plan after determining the resort had failed to provide binding commitments on affordable housing. The modified ...

Fintel reports that on December 10, 2025, JEFFERIES downgraded their outlook for Roche Holding (OTCPK:RHHVF) from Hold to Underperform. Analyst Price Forecast Suggests 50.35% Upside As of December 6, ...

Fintel reports that on December 12, 2025, TD COWEN maintained coverage of Roche Holding (OTCPK:RHHVF) with a Hold recommendation. Analyst Price Forecast Suggests 50.35% Upside As of December 6, 2025, ...

Don’t offer Devin Roche warm bread with butter and jam. If he’s around, don’t raise a glass and wish the bride and groom well ...

The Kent State women's basketball team rewrote the record book with a 117-37 victory during the annual Education Day ...

Roche received expanded approval from the Food and Drug Administration for a test to diagnose breast cancer. The pharmaceutical company said Monday that the FDA approved the PATHWAY HER2 (4B5) test ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche's drug, Perjeta, for the first-line treatment of patients with a type of ...

The U.S. ‍Food and Drug Administration ‌has ‌approved Daiichi Sankyo's therapy in combination with ​Roche's drug ‍for ​the ...

“This process can be likened to a bottle of sparkling water containing dissolved volatiles that exolve when the bottle is ...

Last week, readers were most interested in a story about a PCR test from Roche for vaginitis getting CE marking.